SSR181507, A Dopamine D2 Receptor Antagonist and 5-HT1A Receptor Agonist. II: Behavioral Profile Predictive of an Atypical Antipsychotic Activity
- 6 May 2003
- journal article
- research article
- Published by Springer Nature in Neuropsychopharmacology
- Vol. 28 (11) , 1889-1902
- https://doi.org/10.1038/sj.npp.1300261
Abstract
No abstract availableKeywords
This publication has 36 references indexed in Scilit:
- SSR181507, A Dopamine D2 Receptor Antagonist and 5-HT1A Receptor Agonist. I: Neurochemical and Electrophysiological ProfileNeuropsychopharmacology, 2003
- Do animal models of anxiety predict anxiolytic-like effects of antidepressants?Psychopharmacology, 2002
- Relationship of the Use of Adjunctive Pharmacological Agents to Symptoms and Level of Function in SchizophreniaAmerican Journal of Psychiatry, 2002
- Relapse and Rehospitalisation Rates in Patients with SchizophreniaCNS Drugs, 2002
- The 5-HT1A receptor in schizophrenia: a promising target for novel atypical neuroleptics?Journal of Psychopharmacology, 2001
- Reversal of Haloperidol-Induced Extrapyramidal Side Effects in Cebus Monkeys by 8-Hydroxy-2-(di-n-propylamino)tetralin and Its EnantiomersNeuropsychopharmacology, 1998
- Schizophrenics Kill Themselves Too: A Review of Risk Factors for SuicideSchizophrenia Bulletin, 1990
- Effect of metergoline, fenfluramine, and 8-OHDPAT on catalepsy induced by haloperidol or morphineNaunyn-Schmiedebergs Archiv für experimentelle Pathologie und Pharmakologie, 1988
- Effect of drugs influencing central serotonergic mechanisms on haloperidol-induced catalepsyPsychopharmacology, 1979
- On the mode of action of apomorphineEuropean Journal of Pharmacology, 1973